Immunizing Adult Female Mice with a TcpA-A2-CTB Chimera Provides a High Level of Protection for Their Pups in the Infant Mouse Model of Cholera

PLoS Neglected Tropical Diseases

Volumn 8, Issue 12, 2014, Pages

  Price, Gregory A ^a,b   Holmes, Randall K ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHIMERA; CHOLERA; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; IMMUNIZATION; IMMUNOREACTIVITY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHIMURIUM; SEQUENCE ANALYSIS; WEIGHT REDUCTION; AMINO ACID SEQUENCE; ANIMAL; BLOOD; CHEMISTRY; DISEASE MODEL; FECES; FIMBRIA; GENETICS; IMMUNOLOGY; MOLECULAR GENETICS;

BACTERIUM ANTIBODY; CHOLERA TOXIN; CHOLERA VACCINE; FIMBRIA PROTEIN; HYBRID PROTEIN; RECOMBINANT VACCINE; TCPA PROTEIN, VIBRIO CHOLERAE;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, BACTERIAL; CHOLERA; CHOLERA TOXIN; CHOLERA VACCINES; DISEASE MODELS, ANIMAL; FECES; FEMALE; FIMBRIAE PROTEINS; FIMBRIAE, BACTERIAL; MICE; MOLECULAR SEQUENCE DATA; RECOMBINANT FUSION PROTEINS; VACCINES, SYNTHETIC;

EID: 84928243762     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0003356     Document Type: Article

References (48)

1. WHO (2010) Cholera vaccines: WHO position paper. Wkly Epidemiol Rec 85: 117–128.
2. Sack DA, Sack RB, Nair GB, Siddique AK, (2004) Cholera. Lancet 363: 223–233.
3. Charles RC, Ryan ET, (2011) Cholera in the 21st century. Curr Opin Infect Dis 24: 472–477.
4. Sinclair D, Abba K, Zaman K, Qadri F, Graves PM, (2011) Oral vaccines for preventing cholera. Cochrane Database Syst Rev CD008603.
5. Bhattacharya SK, Sur D, Ali M, Kanungo S, You YA, et al. (2013) 5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial. Lancet Infect Dis 13: 1050–1056.
6. Kabir S, (2014) Critical analysis of compositions and protective efficacies of oral killed cholera vaccines. Clin Vaccine Immunol 21: 1195–1205.
7. Zhang RG, Scott DL, Westbrook ML, Nance S, Spangler BD, et al. (1995) The three-dimensional crystal structure of cholera toxin. J Mol Biol 251: 563–573.
8. Holmgren J, Lonnroth I, Svennerholm L, (1973) Fixation and inactivation of cholera toxin by GM1 ganglioside. Scand J Infect Dis 5: 77–78.
9. De Haan L, Hirst TR, (2004) Cholera toxin: a paradigm for multi-functional engagement of cellular mechanisms (Review). Mol Membr Biol 21: 77–92.
10. Field M, Fromm D, al-Awqati Q, Greenough WB, 3rd (1972) Effect of cholera enterotoxin on ion transport across isolated ileal mucosa. J Clin Invest 51: 796–804.
11. Spangler BD, (1992) Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin. Microbiol Rev 56: 622–647.
12. Taylor RK, Miller VL, Furlong DB, Mekalanos JJ, (1987) Use of phoA gene fusions to identify a pilus colonization factor coordinately regulated with cholera toxin. Proc Natl Acad Sci U S A 84: 2833–2837.
13. Kirn TJ, Lafferty MJ, Sandoe CM, Taylor RK, (2000) Delineation of pilin domains required for bacterial association into microcolonies and intestinal colonization by Vibrio cholerae. Mol Microbiol 35: 896–910.
14. Krebs SJ, Taylor RK, (2011) Protection and attachment of Vibrio cholerae mediated by the toxin-coregulated pilus in the infant mouse model. J Bacteriol 193: 5260–5270.
15. Boesman-Finkelstein M, Finkelstein RA, (1982) Protection in rabbits induced by the Texas Star-SR attenuated A-B+ mutant candidate live oral cholera vaccine. Infect Immun 36: 221–226.
16. Herrington DA, Hall RH, Losonsky G, Mekalanos JJ, Taylor RK, et al. (1988) Toxin, toxin-coregulated pili, and the toxR regulon are essential for Vibrio cholerae pathogenesis in humans. J Exp Med 168: 1487–1492.
17. Levine MM, Black RE, Clements ML, Lanata C, Sears S, et al. (1984) Evaluation in humans of attenuated Vibrio cholerae El Tor Ogawa strain Texas Star-SR as a live oral vaccine. Infect Immun 43: 515–522.
18. Fujita K, Finkelstein RA, (1972) Antitoxic immunity in experimental cholera: comparison of immunity induced perorally and parenterally in mice. J Infect Dis 125: 647–655.
19. Guentzel MN, Berry LJ, (1974) Protection of suckling mice from experimental cholera by maternal immunization: comparison of the efficacy of whole-cell, ribosomal-derived, and enterotoxin immunogens. Infect Immun 10: 167–172.
20. Levine MM, Nalin DR, Craig JP, Hoover D, Bergquist EJ, et al. (1979) Immunity of cholera in man: relative role of antibacterial versus antitoxic immunity. Trans R Soc Trop Med Hyg 73: 3–9.
21. Price GA, McFann K, Holmes RK, (2013) Immunization with cholera toxin B subunit induces high-level protection in the suckling mouse model of cholera. PLoS One 8: e57269.
22. Sun D, Tillman DM, Marion TN, Taylor RK, (1990) Production and characterization of monoclonal antibodies to the toxin coregulated pilus (TCP) of Vibrio cholerae that protect against experimental cholera in infant mice. Serodiagnosis and Immunotherapy in Infectious Disease 4: 73–81.
23. Sun DX, Mekalanos JJ, Taylor RK, (1990) Antibodies directed against the toxin-coregulated pilus isolated from Vibrio cholerae provide protection in the infant mouse experimental cholera model. J Infect Dis 161: 1231–1236.
24. Craig L, Taylor RK, Pique ME, Adair BD, Arvai AS, et al. (2003) Type IV pilin structure and assembly: X-ray and EM analyses of Vibrio cholerae toxin-coregulated pilus and Pseudomonas aeruginosa PAK pilin. Mol Cell 11: 1139–1150.
25. Rollenhagen JE, Kalsy A, Cerda F, John M, Harris JB, et al. (2006) Transcutaneous immunization with toxin-coregulated pilin A induces protective immunity against Vibrio cholerae O1 El Tor challenge in mice. Infect Immun 74: 5834–5839.
26. Price GA, Holmes RK, (2012) Evaluation of TcpF-A2-CTB chimera and evidence of additive protective efficacy of immunizing with TcpF and CTB in the suckling mouse model of cholera. PLoS One 7: e42434.
27. Mizel SB, Bates JT, (2010) Flagellin as an adjuvant: cellular mechanisms and potential. J Immunol 185: 5677–5682.
28. Appleby P, Catty D, (1983) Transmission of immunoglobulin to foetal and neonatal mice. J Reprod Immunol 5: 203–213.
29. Schild S, Nelson EJ, Bishop AL, Camilli A, (2009) Characterization of Vibrio cholerae outer membrane vesicles as a candidate vaccine for cholera. Infect Immun 77: 472–484.
30. Ujiye A, Kobari K, (1970) Protective effect on infections with Vibrio cholerae in suckling mice caused by the passive immunization with milk of immune mothers. J Infect Dis 121: Suppl 121: 150+.
31. Ujiiye A, Nakatomi M, Utsunomiya A, Mitsui K, Sogame S, et al. (1968) Experimental Cholera in Mice I. First Report on the Oral Infection. Tropical Medicine 10: 65–71.
32. Neoh SH, Rowley D, (1972) Protection of infant mice against cholera by antibodies to three antigens of Vibrio cholerae. J Infect Dis 126: 41–47.
33. Wu JY, Wade WF, Taylor RK, (2001) Evaluation of cholera vaccines formulated with toxin-coregulated pilin peptide plus polymer adjuvant in mice. Infect Immun 69: 7695–7702.
34. Kundu J, Mazumder R, Srivastava R, Srivastava BS, (2009) Intranasal immunization with recombinant toxin-coregulated pilus and cholera toxin B subunit protects rabbits against Vibrio cholerae O1 challenge. FEMS Immunol Med Microbiol 56: 179–184.
35. Faruque SM, Sack DA, Sack RB, Colwell RR, Takeda Y, et al. (2003) Emergence and evolution of Vibrio cholerae O139. Proc Natl Acad Sci U S A 100: 1304–1309.
36. Ramamurthy T, Yamasaki S, Takeda Y, Nair GB, (2003) Vibrio cholerae O139 Bengal: odyssey of a fortuitous variant. Microbes Infect 5: 329–344.
37. Bishop AL, Schild S, Patimalla B, Klein B, Camilli A, (2010) Mucosal immunization with Vibrio cholerae outer membrane vesicles provides maternal protection mediated by antilipopolysaccharide antibodies that inhibit bacterial motility. Infect Immun 78: 4402–4420.
38. Leitner DR, Feichter S, Schild-Prufert K, Rechberger GN, Reidl J, et al. (2013) Lipopolysaccharide modifications of a cholera vaccine candidate based on outer membrane vesicles reduce endotoxicity and reveal the major protective antigen. Infect Immun 81: 2379–2393.
39. Tacket CO, Losonsky G, Nataro JP, Comstock L, Michalski J, et al. (1995) Initial clinical studies of CVD 112 Vibrio cholerae O139 live oral vaccine: safety and efficacy against experimental challenge. J Infect Dis 172: 883–886.
40. Tacket CO, Taylor RK, Losonsky G, Lim Y, Nataro JP, et al. (1998) Investigation of the roles of toxin-coregulated pili and mannose-sensitive hemagglutinin pili in the pathogenesis of Vibrio cholerae O139 infection. Infect Immun 66: 692–695.
41. Thelin KH, Taylor RK, (1996) Toxin-coregulated pilus, but not mannose-sensitive hemagglutinin, is required for colonization by Vibrio cholerae O1 El Tor biotype and O139 strains. Infect Immun 64: 2853–2856.
42. Domenighini M, Pizza M, Jobling MG, Holmes RK, Rappuoli R, (1995) Identification of errors among database sequence entries and comparison of correct amino acid sequences for the heat-labile enterotoxins of Escherichia coli and Vibrio cholerae. Mol Microbiol 15: 1165–1167.
43. Finkelstein RA, Burks MF, Zupan A, Dallas WS, Jacob CO, et al. (1987) Epitopes of the cholera family of enterotoxins. Rev Infect Dis 9: 544–561.
44. Rhine JA, Taylor RK, (1994) TcpA pilin sequences and colonization requirements for O1 and O139 Vibrio cholerae. Mol Microbiol 13: 1013–1020.
45. Pasetti MF, Levine MM, (2012) Insights from natural infection-derived immunity to cholera instruct vaccine efforts. Clin Vaccine Immunol 19: 1707–1711.
46. Harris AM, Bhuiyan MS, Chowdhury F, Khan AI, Hossain A, et al. (2009) Antigen-specific memory B-cell responses to Vibrio cholerae O1 infection in Bangladesh. Infect Immun 77: 3850–3856.
47. Harris JB, Podolsky MJ, Bhuiyan TR, Chowdhury F, Khan AI, et al. (2009) Immunologic responses to Vibrio cholerae in patients co-infected with intestinal parasites in Bangladesh. PLoS Negl Trop Dis 3: e403.
48. Arifuzzaman M, Rashu R, Leung DT, Hosen MI, Bhuiyan TR, et al. (2012) Antigen-specific memory T cell responses after vaccination with an oral killed cholera vaccine in Bangladeshi children and comparison to responses in patients with naturally acquired cholera. Clin Vaccine Immunol 19: 1304–1311.